https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-10-10 / Stem Cell Res Ther 2016 10;7(1):149
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-10-10 / Stem Cell Res Ther 2016 10;7(1):1492016-10-10 00:00:002019-02-15 09:00:20Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-10-04 / Oncotarget 2016 Oct;7(40):65042-65051
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-10-04 / Oncotarget 2016 Oct;7(40):65042-650512016-10-04 00:00:002016-10-04 00:00:00Radiofrequency hyperthermia promotes the therapeutic effects on chemotherapeutic-resistant breast cancer when combined with heat shock protein promoter-controlled HSV-TK gene therapy: Toward imaging-guided interventional gene therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-09-29 / Cancer Immunol. Immunother. 2016 12;65(12):1499-1509
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-09-29 / Cancer Immunol. Immunother. 2016 12;65(12):1499-15092016-09-29 00:00:002019-02-15 08:47:26Phase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-09-12 / Biol. Blood Marrow Transplant. 2016 12;22(12):2149-2154
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-09-12 / Biol. Blood Marrow Transplant. 2016 12;22(12):2149-21542016-09-12 00:00:002019-02-15 08:32:47Induction of Immune Response after Allogeneic Wilms‘ Tumor 1 Dendritic Cell Vaccination and Donor Lymphocyte Infusion in Patients with Hematologic Malignancies and Post-Transplantation Relapse
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-08-30 / Oncotarget 2016 Aug;7(35):57367-57378
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-08-30 / Oncotarget 2016 Aug;7(35):57367-573782016-08-30 00:00:002019-02-15 09:18:12Local hyperthermia in head and neck cancer: mechanism, application and advance
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-08-24 / J. Biomed. Sci. 2016 Aug;23(1):64
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-08-24 / J. Biomed. Sci. 2016 Aug;23(1):642016-08-24 00:00:002019-02-15 08:39:07A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-08-14 / Int J Hyperthermia 2016 11;32(7):809-21
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-08-14 / Int J Hyperthermia 2016 11;32(7):809-212016-08-14 00:00:002019-02-15 08:35:47Hyperthermia and radiotherapy with or without chemotherapy in locally advanced cervical cancer: a systematic review with conventional and network meta-analyses
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-08-12 / Int J Hyperthermia 2016 11;32(7):801-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-08-12 / Int J Hyperthermia 2016 11;32(7):801-82016-08-12 00:00:002019-02-15 08:35:46A multicentre randomised clinical trial of chemoradiotherapy plus hyperthermia versus chemoradiotherapy alone in patients with locally advanced cervical cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-08-10 / Expert Rev Vaccines 2017 01;16(1):27-36
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-08-10 / Expert Rev Vaccines 2017 01;16(1):27-362016-08-10 00:00:002019-02-15 08:47:24Advances and challenges: dendritic cell vaccination strategies for glioblastoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-07-29 / Ophthalmology 2016 10;123(10):2265-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-07-29 / Ophthalmology 2016 10;123(10):2265-72016-07-29 00:00:002019-02-15 08:49:46Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma